Endocrine surveillance required for patients receiving immune checkpoint inhibitors

Cancer patients treated with immune checkpoint inhibitors are at risk for developing pituitary, thyroid and glucose metabolism dysfunctions, according to research presented at the American Association of Clinical Endocrinologists Annual Scientific and Clinical Congress.Healio
Source: Society for Endocrinology - Category: Endocrinology Source Type: news